RENAISSANCE TECHNOLOGIES LLC

Position in DYN — Dyne Therapeutics, Inc.

CIK 1037389 NEW YORK, NY

Position in DYN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$9,674,168

+$468,352 QoQ

Shares Held

533,600

+13.4% QoQ

Ownership

0.374%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,447,997,584 across 326 Biotechnology names. DYN ranks #54 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,726,993	$588,750,729
2	INCY	Incyte Corp	3,651,532	$343,682,191
3	CORT	Corcept Therapeutics Inc	5,682,783	$229,072,982
4	VRTX	Vertex Pharmaceuticals Inc / Ma	421,688	$188,300,559
5	JAZZ	Jazz Pharmaceuticals plc	819,374	$154,902,654
6	GMAB	Genmab A/S	4,414,550	$118,442,376
7	INVA	Innoviva, Inc.	4,055,632	$94,496,225
8	ARWR	Arrowhead Pharmaceuticals, Inc.	1,036,495	$64,988,236

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,674,168	533,600	+13.4%	Shares	Sole	2026-05-14
2025-12-31	$9,205,816	470,645	+36.2%	Shares	Sole	2026-02-12
2025-09-30	$4,370,575	345,500	+174.2%	Shares	Sole	2025-11-13
2024-06-30	$4,446,540	126,000	+71.9%	Shares	Sole	2024-08-09
2023-03-31	$844,416	73,300	-31.9%	Shares	Sole	2023-05-12
2022-12-31	$1,248,243	107,700	+2.7%	Shares	Sole	2023-02-13
2022-09-30	$1,332,230	104,900	+15.0%	Shares	Sole	2022-11-14
2022-06-30	$626,544	91,200	+113.6%	Shares	Sole	2022-08-12
2022-03-31	$411,628	42,700	-37.7%	Shares	Sole	2022-05-13
2021-12-31	$814,465	68,500	-51.2%	Shares	Sole	2022-02-11
2021-09-30	$2,281,720	140,500	—	Shares	Sole	2021-11-12
No filing history on record for this holder in this stock.